COCRYSTAL PHARMA, INC. Operating Leases, Rent Expense
COCRYSTAL PHARMA, INC. (COCP) reported Operating Leases, Rent Expense of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2020-11-13
- COCRYSTAL PHARMA, INC. operating leases, rent expense for the quarter ending 2020-09-30 was $0.00.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for the quarter ending 2020-06-30 was $0.00.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for the quarter ending 2020-03-31 was $0.00.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for fiscal 2018 was $77.00K, a 68.18% decline from fiscal 2017.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for fiscal 2017 was $242.00K, a 29.86% decline from fiscal 2016.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for fiscal 2016 was $345.00K, a 8.00% decline from fiscal 2015.
- COCRYSTAL PHARMA, INC. operating leases, rent expense for fiscal 2015 was $375.00K, a 27.12% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 6 month as first filed | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 9 month as first filed | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-13 | ||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $44.00K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $44.00K derived: sum of 3 quarters · filed 2019-08-09 | $66.00K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 | $44.00K derived: sum of 2 quarters · filed 2019-05-10 | $66.00K derived: sum of 3 quarters · filed 2019-05-10 | $81.00K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $66.00K derived: sum of 2 quarters · filed 2019-04-01 | $81.00K derived: sum of 3 quarters · filed 2019-08-09 | $77.00K 10-K · filed 2019-04-01 | |||
| 2018-09-30 | $22.00K 10-Q · filed 2018-11-09 | $37.00K derived: sum of 2 quarters · filed 2019-08-09 | $33.00K 10-Q · filed 2019-11-12 | $133.00K 10-Q · filed 2018-11-09 | $128.00K derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $26.00K 10-Q · filed 2019-08-09 | $22.00K 10-Q · filed 2018-08-09 | $106.00K derived: sum of 3 quarters · filed 2019-08-09 | $157.00K derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $11.00K 10-Q · filed 2019-05-10 | $91.00K derived: sum of 2 quarters · filed 2019-05-10 | $142.00K derived: sum of 3 quarters · filed 2019-05-10 | $205.00K derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $131.00K derived: sum of 2 quarters · filed 2019-04-01 | $194.00K derived: sum of 3 quarters · filed 2019-04-01 | $242.00K 10-K · filed 2019-04-01 | $293.00K 10-K · filed 2018-03-21 | ||
| 2017-09-30 | $51.00K 10-Q · filed 2018-11-09 | $114.00K derived: sum of 2 quarters · filed 2018-11-09 | $162.00K 10-Q · filed 2018-11-09 | $329.00K derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-06-30 | $63.00K 10-Q · filed 2017-08-08 | $111.00K 10-Q · filed 2018-08-09 | $278.00K derived: sum of 3 quarters · filed 2018-05-10 | $337.00K derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2017-03-31 | $47.00K 10-Q · filed 2018-05-10 | $215.00K derived: sum of 2 quarters · filed 2018-05-10 | $274.00K derived: sum of 3 quarters · filed 2018-05-10 | $320.00K derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $227.00K derived: sum of 2 quarters · filed 2018-03-21 | $273.00K derived: sum of 3 quarters · filed 2018-03-21 | $345.00K 10-K · filed 2018-03-21 | |||
| 2016-09-30 | $59.00K 10-Q · filed 2017-11-08 | $105.00K derived: sum of 2 quarters · filed 2017-11-08 | $177.00K 10-Q · filed 2017-11-08 | $361.00K derived: sum of 4 quarters · filed 2018-03-21 | |||
| 2016-06-30 | $46.00K 10-Q · filed 2017-08-08 | $92.00K 10-Q · filed 2017-08-08 | $302.00K derived: sum of 3 quarters · filed 2018-03-21 | $357.00K derived: sum of 4 quarters · filed 2018-03-21 | |||
| 2016-03-31 | $46.00K 10-Q · filed 2017-05-10 | $256.00K derived: sum of 2 quarters · filed 2018-03-21 | $311.00K derived: sum of 3 quarters · filed 2018-03-21 | $356.00K derived: sum of 4 quarters · filed 2018-03-21 | |||
| 2015-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $265.00K derived: sum of 2 quarters · filed 2018-03-21 | $310.00K derived: sum of 3 quarters · filed 2018-03-21 | $375.00K 10-K · filed 2018-03-21 | |||
| 2015-09-30 | $55.00K 10-Q · filed 2016-11-09 | $100.00K derived: sum of 2 quarters · filed 2016-11-09 | $165.00K 10-Q · filed 2016-11-09 | ||||
| 2015-06-30 | $45.00K 10-Q · filed 2016-08-09 | $90.00K 10-Q · filed 2016-08-09 | |||||
| 2015-03-31 | $45.00K 10-Q · filed 2016-05-10 | ||||||
| 2014-12-31 | $295.00K 10-K · filed 2017-03-31 | ||||||
| 2013-12-31 | -$22.71K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $75.78K derived: sum of 2 quarters · filed 2016-03-15 | $171.69K derived: sum of 3 quarters · filed 2016-03-15 | $295.00K 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $98.49K 10-Q · filed 2013-11-18 | $194.41K derived: sum of 2 quarters · filed 2013-11-18 | $317.71K 10-Q · filed 2013-11-18 | $47.13K derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2013-06-30 | $95.92K 10-Q · filed 2013-08-15 | $203.54K 10-Q · filed 2013-08-15 | -$51.36K derived: sum of 3 quarters · filed 2015-03-31 | $82.24K derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2013-03-31 | $107.60K 10-Q · filed 2013-05-10 | -$147.27K derived: sum of 2 quarters · filed 2015-03-31 | -$13.68K derived: sum of 3 quarters · filed 2015-03-31 | $128.41K derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2012-12-31 | -$254.88K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$121.28K derived: sum of 2 quarters · filed 2015-03-31 | $20.80K derived: sum of 3 quarters · filed 2015-03-31 | $196.00K 10-K · filed 2015-03-31 | |||
| 2012-09-30 | $133.59K 10-Q · filed 2013-11-18 | $275.68K derived: sum of 2 quarters · filed 2013-11-18 | $450.88K 10-Q · filed 2013-11-18 | ||||
| 2012-06-30 | $142.08K 10-Q · filed 2013-08-15 | $317.28K 10-Q · filed 2013-08-15 | |||||
| 2012-03-31 | $175.20K 10-Q · filed 2013-05-10 | ||||||
| 2011-09-30 | $137.28K 10-Q · filed 2012-11-14 | $316.13K derived: sum of 2 quarters · filed 2012-11-14 | $474.61K 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $178.85K 10-Q/A · filed 2012-09-28 | $337.33K 10-Q/A · filed 2012-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |